Afghanistan vs Chile: New cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Chile
100.0%
in 2024
Afghanistan rank
1st
Chile rank
1st
New cases tested for RR-/MDR-TB over time
- Afghanistan
- Chile
How they compare
Afghanistan currently reports 100.0% against 100.0% in Chile, a difference of 0.0%.
Across all 13 years both countries report, Chile has been ahead every year.
Afghanistan ranks 1st and Chile ranks 1st of 192 countries.
Chile has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10.9% | 65.3% | 54.4% | Chile |
| 2020s | 68.8% | 95.2% | 26.4% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Afghanistan or Chile?
- Afghanistan, at 100.0% against 100.0% in Chile as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Afghanistan and Chile?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Chile?
- 13 years are reported by both, from 2010 to 2024.
- How do Afghanistan and Chile rank globally for new cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Chile ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.